1 | A-623 or AMG 623 | - | - | - | - | 1件: 66 66 💬
|
2 | A07ea06 | - | - | - | - | 1件: 66 66 💬
|
3 | Abelmoschus manihot | - | - | - | - | 1件: 66 66 💬
|
4 | ACE inhibitor | - | - | - | - | 1件: 66 66 💬
|
5 | ACE inhibitor or angiotensin receptor antagonist | - | - | - | - | 1件: 66 66 💬
|
6 | ACE/ARB | - | - | - | - | 1件: 66 66 💬
|
7 | Acei | - | - | - | - | 2件: 66 66, 224 💬
|
8 | Acei/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬
|
9 | Acth (acthar) GEL | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 💬
|
10 | Acthar 80 unit injection | - | - | - | - | 1件: 66 66 💬
|
11 | Acthib - polvere E solvente PER soluzione iniettabile 1 flaconcino polvere+1 siringa preriempita solvente 0.5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
12 | ADX-097 | - | - | - | - | 1件: 66 66 💬
|
13 | Aliskiren | 1件: Aliskiren Aliskiren | 2件: Aliskiren
Aliskiren
,
Aliskiren fumarate
💬
| 1件: REN REN 💬
| 3件: Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 66 66, 167, 222 💬
|
14 | Allopurinol | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
15 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
16 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
17 | ALXN2050 | - | - | - | - | 3件: 11 11, 62, 66 💬
|
18 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
19 | Angiotensin | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 17 17, 66, 218, 222, 224 💬
|
20 | Angiotensin blockade | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
21 | Angiotensin II | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 💬
|
22 | ANTI-CD19/bcma CAR NK cells | - | - | - | - | 1件: 66 66 💬
|
23 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 💬
|
24 | ARB | - | - | - | - | 1件: 66 66 💬
|
25 | ARO-C3 | - | - | - | - | 1件: 66 66 💬
|
26 | ARO-CFB | - | - | - | - | 1件: 66 66 💬
|
27 | Artesunate | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 4件: 18 18, 66, 86, 96 💬
|
28 | AT-1501 | - | - | - | - | 1件: 66 66 💬
|
29 | Atacicept | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 5件: 13 13, 46, 49, 66, 222 💬
|
30 | Atacicept 150 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
31 | Atacicept 25 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 66 💬
|
32 | Atacicept 75 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
33 | ATG-F | - | - | - | - | 1件: 66 66 💬
|
34 | Atrasentan | 1件: Atrasentan Atrasentan | 1件: Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 66 66, 218, 222 💬
|
35 | Avacopan | 1件: Avacopan Avacopan | 1件: Avacopan
Avacopan
💬
| 1件: C5AR1 C5AR1 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | 4件: 43 43, 44, 66, 222 💬
|
36 | AVB-S6-500 | 1件: Batiraxcept Batiraxcept | 1件: Batiraxcept
Batiraxcept
💬
| 1件: AXL AXL 💬
| 1件: Efferocytosis Efferocytosis 💬 | 1件: 66 66 💬
|
37 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
38 | Azilsartan | 1件: Azilsartan medoxomil Azilsartan medoxomil | 3件: Azilsartan medoxomil
Azilsartan medoxomil
,
Azilsartan
,
Azilsartan kamedoxomil
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
39 | Bardoxolone methyl capsules | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 4件: 66 66, 67, 86, 222 💬
|
40 | BCX9930 | - | - | - | - | 3件: 62 62, 66, 222 💬
|
41 | BCX9930 hydrochloride | - | - | - | - | 3件: 62 62, 66, 222 💬
|
42 | Belimumab | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
|
43 | Benlysta | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 49 49, 66, 222 💬
|
44 | Bexsero - sospensione iniettabile - USO intramuscolare - siringa preriempita (vetro) - 0.5ML - 1 siringa preriempita CON AGO | - | - | - | - | 2件: 62 62, 66 💬
|
45 | BIO-kult advanced | - | - | - | - | 1件: 66 66 💬
|
46 | BION-1301 | - | - | - | - | 1件: 66 66 💬
|
47 | BION-1301 multiple doses | - | - | - | - | 1件: 66 66 💬
|
48 | BION-1301 single dose | - | - | - | - | 1件: 66 66 💬
|
49 | Blisibimod | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬
| - | - | 5件: 43 43, 44, 49, 63, 66 💬
|
50 | Blisibimod injection | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬
| - | - | 1件: 66 66 💬
|
51 | Blood sample | - | - | - | - | 28件: 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
52 | BNJ441 | - | - | - | - | 1件: 66 66 💬
|
53 | Bortezomib | 2件: Bortezomib Bortezomib, Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
|
54 | Budesonide | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 66 66, 93, 94, 95, 96, 97, 98 💬
|
55 | C09 | - | - | - | - | 1件: 66 66 💬
|
56 | Calcitriol | 1件: Calcitriol Calcitriol | 1件: Calcitriol
Calcitriol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 18 18, 37, 46, 49, 66, 96, 235, 326 💬
|
57 | CCX168 | - | - | - | - | 6件: 43 43, 44, 49, 66, 109, 222 💬
|
58 | Cemdisiran | 1件: Cemdisiran Cemdisiran | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
59 | Chinese herb prescription granule plus prednisone | - | - | - | - | 1件: 66 66 💬
|
60 | Cilazapril | 1件: Cilazapril Cilazapril | 2件: Cilazapril
Cilazapril
,
Cilazapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 66 66 💬
|
61 | CM313 | - | - | - | - | 1件: 66 66 💬
|
62 | CM338 | - | - | - | - | 1件: 66 66 💬
|
63 | Continue their usual therapy | - | - | - | - | 1件: 66 66 💬
|
64 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
65 | Corticotherapy | - | - | - | - | 1件: 66 66 💬
|
66 | Creatinine | 1件: Creatinine Creatinine | 1件: Creatinine
Creatinine
💬
| - | - | 6件: 2 2, 46, 60, 66, 70, 222 💬
|
67 | Cyclophosphamid | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 66 66, 220 💬
|
68 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
69 | Dapagliflozin | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 10件: 6 6, 28, 49, 66, 67, 86, 88, 215, 218, 222 💬
|
70 | Decortin H | - | - | - | - | 2件: 66 66, 145 💬
|
71 | Dihuang | 1件: Rehmannia glutinosa root Rehmannia glutinosa root | 1件: Rehmannia root
Rehmannia root
💬
| - | - | 2件: 46 46, 66 💬
|
72 | Dipyridamole | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 46 46, 51, 66, 96 💬
|
73 | Enalapril | 1件: Enalapril Enalapril | 2件: Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 13 13, 66, 113, 210, 222, 279 💬
|
74 | Enalapril valsartan methylprednisone | 1件: Enalapril Enalapril | 2件: Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 66 66 💬
|
75 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
76 | Felzartamab | 1件: Felzartamab Felzartamab | - | - | - | 2件: 66 66, 222 💬
|
77 | Finerenone | 1件: Finerenone Finerenone | 1件: Finerenone
Finerenone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 66 66, 218, 222, 224 💬
|
78 | FOS | - | - | - | - | 2件: 66 66, 96 💬
|
79 | Fostamatinib 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
80 | Fostamatinib 100 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
81 | Fostamatinib 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
82 | Fostamatinib 150 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
83 | Fostamatinib disodium | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 61, 63, 66 💬
|
84 | Fostamatinib disodium tablet 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
85 | Fostamatinib disodium tablet 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
86 | Gastrus | - | - | - | - | 1件: 66 66 💬
|
87 | Glucocorticoid | - | - | - | - | 6件: 46 46, 49, 66, 113, 220, 228 💬
|
88 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 9件: 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
89 | GSK1550188 | - | - | - | - | 4件: 11 11, 49, 66, 222 💬
|
90 | GUT-directed budesonide and SOC | - | - | - | - | 1件: 66 66 💬
|
91 | Haemophilus influenzae | - | - | - | - | 2件: 62 62, 66 💬
|
92 | Henagliflozin | 1件: Henagliflozin Henagliflozin | - | - | - | 2件: 66 66, 218 💬
|
93 | Hiberix - polvere E solvente PER soluzione iniettabile PER USO intramuscolare 1 flaconcino DI polvere + 1 siringa preriempita DI solvente DA 0.5 ML | - | - | - | - | 3件: 61 61, 62, 66 💬
|
94 | High DOSE-VIS649 | - | - | - | - | 1件: 66 66 💬
|
95 | HR19042 capsule | - | - | - | - | 2件: 66 66, 95 💬
|
96 | HR19042 capsules | - | - | - | - | 2件: 66 66, 95 💬
|
97 | HRS-5965 | - | - | - | - | 1件: 66 66 💬
|
98 | HRS-5965 capsules | - | - | - | - | 2件: 62 62, 66 💬
|
99 | HRS-5965 tablets | - | - | - | - | 2件: 62 62, 66 💬
|
100 | HS-10390 | - | - | - | - | 1件: 66 66 💬
|
101 | HS-10390 tablet | - | - | - | - | 2件: 66 66, 222 💬
|
102 | HSK39297 100mgbid | - | - | - | - | 1件: 66 66 💬
|
103 | HSK39297 200mgqd | - | - | - | - | 1件: 66 66 💬
|
104 | HSK39297 50mgbid | - | - | - | - | 1件: 66 66 💬
|
105 | Human soluble recombinant FC-gamma receptor IIB | - | - | - | - | 1件: 66 66 💬
|
106 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
107 | Hydroxychloroquine and SOC | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 1件: 66 66 💬
|
108 | Hydroxychloroquine oral tablet | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 2件: 63 63, 66 💬
|
109 | Hydroxychloroquine sulfate | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 4件: 13 13, 46, 53, 66 💬
|
110 | Immune suppressant | - | - | - | - | 1件: 66 66 💬
|
111 | Immunosuppressants | - | - | - | - | 1件: 66 66 💬
|
112 | Immunosuppressive treatment | - | - | - | - | 1件: 66 66 💬
|
113 | Inhibace/cozaar | - | - | - | - | 1件: 66 66 💬
|
114 | Intensive supportive care | - | - | - | - | 1件: 66 66 💬
|
115 | Intervention FOR incipient patients AT LOW risk OF disease progression | - | - | - | - | 1件: 66 66 💬
|
116 | Intervention FOR patients AT high risk OF disease progression | - | - | - | - | 1件: 66 66 💬
|
117 | Intravenous rituximab | - | - | - | - | 1件: 66 66 💬
|
118 | Ionis-FB-LRX | - | - | - | - | 1件: 66 66 💬
|
119 | Iptacopan | 1件: Iptacopan Iptacopan | 2件: Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| 1件: CFB CFB 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 6件: 11 11, 61, 62, 66, 109, 222 💬
|
120 | Iptacopan hydrochloride | 1件: Iptacopan Iptacopan | 2件: Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| 1件: CFB CFB 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 4件: 61 61, 66, 109, 222 💬
|
121 | Irbesartan | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 4件: 66 66, 167, 168, 222 💬
|
122 | Irbesartan tablets (approved IN THE USA. reference listed drug avapro) NDC # 43547-0374-03 | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 💬
|
123 | KP104 | - | - | - | - | 3件: 49 49, 62, 66 💬
|
124 | Leflunomide | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 13件: 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 224, 270, 271, 300 💬
|
125 | Leflunomide 20 MG+prednisone 0.5MG/KG/D | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 66 66 💬
|
126 | Lisinopril | 1件: Lisinopril Lisinopril | 2件: Lisinopril
Lisinopril
,
Lisinopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 5件: 19 19, 46, 66, 67, 113 💬
|
127 | LNP023 | - | - | - | - | 5件: 61 61, 62, 66, 109, 222 💬
|
128 | LNP023 hydrochlori | - | - | - | - | 1件: 66 66 💬
|
129 | Losartan | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
130 | LOW antigen content diet | - | - | - | - | 1件: 66 66 💬
|
131 | LOW DOSE-VIS649 | - | - | - | - | 1件: 66 66 💬
|
132 | MASP-2 antibody, OMS00620646, OMS620646 | 1件: Narsoplimab Narsoplimab | 1件: Narsoplimab
Narsoplimab
💬
| 1件: MASP2 MASP2 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 66 66 💬
|
133 | Medium DOSE-VIS649 | - | - | - | - | 1件: 66 66 💬
|
134 | Menatetrenone | 1件: Menatetrenone Menatetrenone | 1件: Menatetrenone
Menatetrenone
💬
| - | - | 2件: 66 66, 97 💬
|
135 | Menveo - polv.E soluz.PER soluz. iniett.-USO intramuscolare-comp. coniug.liofilizz.mena:flac.(vetro) comp. goniug.liqui.mencwy:flac.(vetro)-1 flac+1flac | - | - | - | - | 2件: 62 62, 66 💬
|
136 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
137 | Methylprednisolon | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 14 14, 51, 66 💬
|
138 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
139 | Methylprednisolone mylan GéNérique | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
140 | Methylprednisolone pulse | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 220 💬
|
141 | Methylprednisolone succinate | 2件: Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | 4件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 66 💬
|
142 | Metilprednisolone sodio succinato | - | - | - | - | 4件: 13 13, 14, 56, 66 💬
|
143 | Mezagitamab | 1件: Mezagitamab Mezagitamab | 1件: Mezagitamab
Mezagitamab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 63 63, 66 💬
|
144 | Mizoribine | 1件: Mizoribine Mizoribine | 1件: Mizoribine
Mizoribine
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 8件: 46 46, 49, 51, 53, 66, 94, 222, 224 💬
|
145 | MMF | - | - | - | - | 15件: 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
|
146 | MOR03087 | - | - | - | - | 2件: 66 66, 222 💬
|
147 | MOR202 | - | - | - | - | 2件: 66 66, 222 💬
|
148 | MY008211A tablets | - | - | - | - | 2件: 62 62, 66 💬
|
149 | Mycophenolat-natrium | - | - | - | - | 1件: 66 66 💬
|
150 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
151 | Mycophenolate mofetil (MMF) and SOC | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 66 66 💬
|
152 | Mycophenolate mofetil plus lower dose OF prednisone | 3件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid, Prednisone | 5件: Prednisone
Prednisone
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 3件: IMPDH IMPDH, IMPDH, NR3C1 💬
| 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 66 66 💬
|
153 | Mycophenolate sodium | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 3件: 53 53, 66, 222 💬
|
154 | Mycophenolic acid | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 8件: 11 11, 43, 49, 51, 60, 66, 96, 222 💬
|
155 | Mycophenolic sodium | - | - | - | - | 2件: 66 66, 222 💬
|
156 | Myfortic | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 4件: 49 49, 66, 222, 228 💬
|
157 | Myfortic 180MG tablets | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 66 66, 222 💬
|
158 | Myfortic 360MG tablets | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 66 66, 222 💬
|
159 | Narsoplimab | 1件: Narsoplimab Narsoplimab | 1件: Narsoplimab
Narsoplimab
💬
| 1件: MASP2 MASP2 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 66 66, 222 💬
|
160 | Nefecon | - | - | - | - | 1件: 66 66 💬
|
161 | Nefecon 16MG daily | - | - | - | - | 1件: 66 66 💬
|
162 | NM8074 | - | - | - | - | 4件: 50 50, 62, 66, 109 💬
|
163 | NON-steroidal mineralocorticoid receptor antagonist and SOC | - | - | - | - | 1件: 66 66 💬
|
164 | NTQ5082 capsules 100 MG | - | - | - | - | 1件: 66 66 💬
|
165 | NTQ5082 capsules 200 MG | - | - | - | - | 1件: 66 66 💬
|
166 | NTQ5082 capsules 300 MG | - | - | - | - | 1件: 66 66 💬
|
167 | Omega-3 fatty acid ethylester90 | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 66 66 💬
|
168 | Omega-3 fatty acid fish OIL supplement | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 66 66 💬
|
169 | OMS721 | - | - | - | - | 4件: 64 64, 66, 109, 222 💬
|
170 | OPL-CCL2-LPM | - | - | - | - | 1件: 66 66 💬
|
171 | Optimized supportive care | - | - | - | - | 1件: 66 66 💬
|
172 | Oral prednisolone and SOC | - | - | - | - | 1件: 66 66 💬
|
173 | OVER-encapsulated 150 MG irbesartan tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
174 | OVER-encapsulated irbesartan tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 💬
|
175 | Paricalcitol | 1件: Paricalcitol Paricalcitol | 1件: Paricalcitol
Paricalcitol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 19 19, 66, 218, 238, 298 💬
|
176 | Pneumovax – soluzione iniettabile IN siringa preriempita DA 0,5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
177 | Potassium | 1件: Potassium Potassium | 1件: Potassium
Potassium
💬
| - | - | 3件: 66 66, 67, 115 💬
|
178 | Prednisolon | - | - | - | - | 7件: 46 46, 51, 66, 95, 96, 97, 251 💬
|
179 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
180 | Prednisolone plus cyclophosphamide | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
181 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
182 | Prednisone 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 66 💬
|
183 | Prednisone alone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 66 💬
|
184 | Prednisone and cyclophosphamide | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
185 | Prednisone arrow 20MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
186 | Prednisone arrow 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
187 | Prednisone IN full dose | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
188 | Prednisone or prednisolone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 84 💬
|
189 | Prednisone plus cyclophosphamide | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
190 | Probiotics combined with enteric-coated budesonide capsule | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
191 | Probucol | 1件: Probucol Probucol | 1件: Probucol
Probucol
💬
| - | - | 3件: 21 21, 66, 79 💬
|
192 | Proline | 1件: Proline Proline | 1件: Proline
Proline
💬
| - | - | 1件: 66 66 💬
|
193 | Protectis | - | - | - | - | 1件: 66 66 💬
|
194 | R935788 | - | - | - | - | 4件: 46 46, 61, 63, 66 💬
|
195 | Ramipril | 1件: Ramipril Ramipril | 1件: Ramipril
Ramipril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 46 46, 49, 66, 67, 113, 218, 257 💬
|
196 | Rapamune | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 7件: 60 60, 66, 67, 84, 158, 278, 280 💬
|
197 | RAS | - | - | - | - | 1件: 66 66 💬
|
198 | RAS 2410 | - | - | - | - | 1件: 66 66 💬
|
199 | RAS inhibitor | - | - | - | - | 1件: 66 66 💬
|
200 | Ravulizumab | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
201 | RC18 160MG | - | - | - | - | 3件: 11 11, 13, 66 💬
|
202 | RC18 240MG | - | - | - | - | 2件: 13 13, 66 💬
|
203 | RE-021 | - | - | - | - | 3件: 66 66, 218, 222 💬
|
204 | REH-acteoside | - | - | - | - | 1件: 66 66 💬
|
205 | Risedronate | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 3件: 46 46, 66, 96 💬
|
206 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
207 | SC0062 high dose | - | - | - | - | 1件: 66 66 💬
|
208 | SC0062 LOW dose | - | - | - | - | 1件: 66 66 💬
|
209 | SC0062 medium dose | - | - | - | - | 1件: 66 66 💬
|
210 | SC0062 strength 10MG | - | - | - | - | 1件: 66 66 💬
|
211 | SCTC21C | - | - | - | - | 1件: 66 66 💬
|
212 | SGB-9768 | - | - | - | - | 2件: 66 66, 222 💬
|
213 | SHR-2010 injection | - | - | - | - | 1件: 66 66 💬
|
214 | Sibeprenlimab | 1件: Sibeprenlimab Sibeprenlimab | 1件: Sibeprenlimab
Sibeprenlimab
💬
| 1件: TNFSF13 TNFSF13 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬 | 1件: 66 66 💬
|
215 | Simulect | 1件: Basiliximab Basiliximab | 1件: Basiliximab
Basiliximab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 66 66, 97 💬
|
216 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 19件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
|
217 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
218 | Sirolimus (study drug)+ACE inhibitor + statin | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 66 66 💬
|
219 | SM101 | - | - | - | - | 3件: 49 49, 63, 66 💬
|
220 | Solu medrol - 1000 MG/16 ML polvere E solvente PER soluzione iniettabile 1 flacone DI polvere DA 1000 MG+ 1 flacone solvente DA 16 ML | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
221 | Sparsentan | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 66 66, 218, 222 💬
|
222 | Sparsentan compresse | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
223 | Sparsentan tablets/OVER-encapsulated sparsentan tablets | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
224 | Sparsentan tablets/OVER-encapsulated spasenten tablets | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
225 | Sparsentan tablets/overencapsulated sparsentan tablets | 1件: Sparsentan Sparsentan | 1件: Sparsentan
Sparsentan
💬
| 2件: AGTR1 AGTR1, EDNRA 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
226 | Steroids plus azathioprine | - | - | - | - | 1件: 66 66 💬
|
227 | Supportive and immunosuppressive therapy | - | - | - | - | 1件: 66 66 💬
|
228 | Supportive therapy | - | - | - | - | 1件: 66 66 💬
|
229 | Supportive therapy with: ACE-inhibitor / ARB / statin | - | - | - | - | 1件: 66 66 💬
|
230 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
231 | Tailored diet | - | - | - | - | 1件: 66 66 💬
|
232 | Tarpeyo 4 MG delayed release oral capsule | - | - | - | - | 1件: 66 66 💬
|
233 | Telitacicept | 1件: Telitacicept Telitacicept | - | - | - | 11件: 11 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
|
234 | Telitacicept 160MG | 1件: Telitacicept Telitacicept | - | - | - | 2件: 49 49, 66 💬
|
235 | Telitacicept 240MG | 1件: Telitacicept Telitacicept | - | - | - | 1件: 66 66 💬
|
236 | Telmisartan | 1件: Telmisartan Telmisartan | 1件: Telmisartan
Telmisartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 67 💬
|
237 | Tetracycline | 1件: Tetracycline Tetracycline | 2件: Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | 5件: 13 13, 46, 53, 66, 97 💬
|
238 | THE YI-QI-QING-JIE herbal compound | - | - | - | - | 1件: 66 66 💬
|
239 | Tofacitinib | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 19件: 35 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
|
240 | Tripterygium | 1件: Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | 4件: 66 66, 162, 224, 271 💬
|
241 | Ultomiris | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
242 | Ultomiris 300 MG/30 ML | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 66 66 💬
|
243 | Vaccino contro IL memingococco DI gruppo B | - | - | - | - | 3件: 61 61, 62, 66 💬
|
244 | Vaccino haemophilus influenzae B coniugato CON tossoidetetanico | - | - | - | - | 3件: 61 61, 62, 66 💬
|
245 | Vaccino pneumococcico | - | - | - | - | 2件: 62 62, 66 💬
|
246 | Valsartan | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 57 57, 58, 66, 75, 210, 222, 224 💬
|
247 | VIS649 | - | - | - | - | 1件: 66 66 💬
|
248 | VT-001 | - | - | - | - | 1件: 66 66 💬
|
249 | Warfarin | 1件: Warfarin Warfarin | 3件: Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 10件: 6 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
|
250 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
251 | Zigakibart | 1件: Zigakibart Zigakibart | 1件: Zigakibart
Zigakibart
💬
| 1件: TNFSF13 TNFSF13 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬 | 1件: 66 66 💬
|